Location San Francisco, California, United States Regions San Francisco Bay Area, West Coast, Western US Gender Male
Facebook View on Facebook LinkedIn View on LinkedIn
Benaron is a founder of multiple biotechnology start-ups, including Spectros, FirstScan (in oncology), Xenogen (in Drug Discovery tools, went public, then acquired by Caliper, then acquired with Caliper by Perkin-Elmer for $600 million), and Insite (in oximetry and glucose monitoring, spun out to Vital Insite for Blood pressure monitoring with
technology acquired by Masimo).
He has an MD from Harvard, a Health Sciences degree from MIT, and attended as a physician in Intensive Care at Stanford University Medical School. He holds over 30 US and International patents in biomedical devices, methods, and technology. He also serves on the Board at companies outside of Spectros.
